Welcome to our September issue—a heartfelt edition packed with breakthroughs, compassion, and a little something for every corner of the veterinary world.
This month, we’re honored to spotlight UK’s Dr. Sid Sudunagunta, our cover star and the King of Hearts of veterinary cardiology. From his pioneering work in minimally invasive interventions to his passion for teaching (and his poker-faced love for cats named Havoc and Dorito), Dr. Sid reminds us that the best medicine blends expertise with humanity. Don’t miss his NAVLE prep collaboration with Vet Candy—because even the sharpest minds believe in sharing the knowledge.
Speaking of hearts, we’re celebrating a landmark moment in feline medicine: the FDA’s conditional approval of Felycin®-CA1, the first-ever drug for subclinical HCM in cats. For the 1 in 7 cats at risk, this isn’t just progress—it’s hope in a tablet. Meanwhile, our deep dive into feline HCM genetics reveals how much we’ve learned (and how much remains a mystery). Spoiler: Cats continue to out
